Patent holdings for IPC class A61K 31/4709

Total number of patents in this class: 5143

10-year publication summary

368
384
401
368
444
436
410
416
330
96
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
Janssen Pharmaceutica N.V.
3839
83
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
616
77
Bristol-myers Squibb Company
5080
57
Boehringer Ingelheim International GmbH
4629
55
F. Hoffmann-La Roche AG
7958
53
Centre National de La Recherche Scientifique
9632
53
Vertex Pharmaceuticals Incorporated
1581
50
Arog Pharmaceuticals, Inc.
49
45
The Regents of the University of California
18943
43
Gilead Sciences, Inc.
1879
43
Novartis AG
11238
36
Merck Patent GmbH
5909
36
Kura Oncology, Inc.
105
36
Amgen Inc.
3779
35
Institut Curie
531
35
Taisho Pharmaceutical Co., Ltd.
844
35
Abivax
105
33
Forma Therapeutics, Inc.
164
33
Universite de Montpellier
920
32
Merck Sharp & Dohme LLC
3689
32
Other owners 4241